Some studies show that HER-2 protein exhibits abnormal expression in 6-35% gastric cancer tissues[29,30], and has been used as the therapeutic target for clinical patients with gastric cancer[31], therefore, HER-2 protein owns great potential in imaging and therapy of gastric cancer. Here, ERBB2 is linked to gastric cancer.